Mitsuyoshi Yoshimoto
8PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Nov 03, 2025
Enhanced Radionuclide Therapy via the Conjugation of Pentadecanoic Acids With 225Ac- and 177Lu-Labeled RGD Peptides.Mitsuyoshi Yoshimoto, Shun-Ichi Wada, Yukie Yoshii
|Jan 25, 2025
Long-Term Therapeutic Effects of 225Ac-DOTA-E[c(RGDfK)]2 Induced by Radiosensitization via G2/M Arrest in Pancreatic Ductal Adenocarcinoma.Mitsuyoshi Yoshimoto, Kohshin Washiyama, Kazunobu Ohnuki
|Sep 24, 2024
αvβ3 integrin-targeted magnetic resonance imaging in a pancreatic cancer mouse model using RGD-modified liposomes encapsulated with Fe-deferoxamine.Mitsuyoshi Yoshimoto, Takuya Hayakawa, Masayuki Yamaguchi
|Jun 06, 2022
Protection from contamination by 211At, an enigmatic but promising alpha-particle-emitting radionuclide.Kazunobu Ohnuki, Mitsuyoshi Yoshimoto, Hiromitsu Haba
|Oct 23, 2021
Evaluation of Aminopolycarboxylate Chelators for Whole-Body Clearance of Free 225Ac: A Feasibility Study to Reduce Unexpected Radiation Exposure during Targeted Alpha Therapy.Mitsuyoshi Yoshimoto, Yukie Yoshii, Hiroki Matsumoto
|Oct 10, 2020
Radiological protection and biological COVID-19 protection in the nuclear medicine department.Kazunobu Ohnuki, Mitsuyoshi Yoshimoto, Hirofumi Fujii
Pageof 2
